Huaxi Engine Biotech (Tianjin) Co., Ltd. was established with Qu Jiahao as its legal representative and a registered capital of RMB 10 million (approximately USD 1.39 million). The company’s business scope includes R&D of biochemical products, medical research and experimental development, industrial enzyme development, AI infrastructure and technology platform services, and AI public service platform consulting. According to Qichacha’s equity penetration data, the company is jointly owned by Hainan Jiaquan Biotech Co., Ltd., a subsidiary of Bloomage Biotech, and Tianjin Zhihe Yuansheng Enterprise Management Consulting Partnership (Limited Partnership), among others. (Source: Securities Times)
Bloomage (formerly known as Bloomage Freda Biopharm Co., Ltd.) embarked on its journey in 2000, venturing into the production of hyaluronic acid through microbial fermentation. With over two decades of unwavering commitment and ceaseless innovation, Bloomage has established itself as a prominent global biotechnology and biomaterial company that specializes in the industrialization of hyaluronic acid.
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE